Alpine Bank Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$144K Buy
+3,000
New +$129K 0.02% 191
2025
Q4
Sell
-3,000
Closed -$166K 317
2025
Q3
$166K Sell
3,000
-996
-25% -$58.3K 0.02% 169
2025
Q2
$276K Sell
3,996
-1,122
-22% -$76.3K 0.04% 122
2025
Q1
$355K Buy
+5,118
New +$423K 0.06% 108
2024
Q3
$609K Buy
+5,118
New +$683K 0.1% 97

Other funds holding NVO

Alpine Bank Wealth Management's NVO Position: Q2 2026 in Review

Alpine Bank Wealth Management opened a new position in Novo Nordisk (NVO) in Q2 2026: 3,000 shares worth $144K. The stake represents 0.02% of the portfolio and ranks #191 among its holdings. This is a return to the name: Alpine Bank Wealth Management previously reported a position in NVO as recently as Q3 2025.

Alpine Bank Wealth Management first reported a position in NVO in Q3 2024 and has held it in 5 quarters since. The position peaked at $609K in Q3 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Alpine Bank Wealth Management held 3,000 shares of Novo Nordisk worth $144K as of Q2 2026.
  • Novo Nordisk was a new Alpine Bank Wealth Management position in Q2 2026.
  • Novo Nordisk made up 0.02% of Alpine Bank Wealth Management's portfolio in Q2 2026, its #191 holding.
  • Alpine Bank Wealth Management first reported a position in Novo Nordisk in Q3 2024 and has held it in 5 quarters since.
  • Alpine Bank Wealth Management's Novo Nordisk position peaked at $609K in Q3 2024.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Alpine Bank Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.